CVS Health (CVS) closed the most recent trading day at $67.91, moving +0.5% from the previous trading session. This change lagged the S&P 500's 1.08% gain on the day. Meanwhile, the Dow gained 0.92%, ...

CVS Health is reevaluating its role in healthcare as financial pressures mount. The company, along with other major retailers ...

Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...

Moderately bullish options flow in CVS Health trading today. 79K contracts traded in the pharmacy and health services name with calls leading ...

CVS Health Corp. closed 17.46% below its 52-week high of $80.75, which the company achieved on March 28th.

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products ...

CVS Health Corp. flashing bullish signal with Golden Cross formation and strong technicals. Weight management program also ...

The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.

Oct. 28, 2024 — As cannabis is legalized and is more accessible in various forms across the country, there is increasing concern among health care providers about ... New Study Highlights the ...

The Menopause Friendly Accreditation from MiDOViA, a program that launched in the U.K. to improve workplaces for women in ...

The government's free at-home COVID-19 test distribution program is no longer accepting orders, its website says. Here's how to get tests in the meantime.